Article

7 pearls for penetrating keratoplasty in pediatrics

Author(s):

Evaluate patients’ social situations; educate parents about their participation

Surgeons can achieve good visual results in children with corneal diseases by following these pearls.

Reviewed by Gerald W. Zaidman, FAAO, FACS

Corneal diseases are thought to be responsible for 10% of worldwide blindness in young patients and are frequent causes of blindness in developed and underdeveloped countries. However, unlike in adults, these diseases are more challenging in children, said Gerald W. Zaidman, MD.

“The patients are different,” said Dr. Zaidman, professor of ophthalmology, New York Medical College, and vice chairman of ophthalmology, Westchester Medical Center, both in Valhalla, NY.

“The eyes are different,” he said. “The diseases are different. The surgery and the anesthesia are different.” Dr. Zaidman shared pearls for achieving successful outcomes before and after penetrating keratoplasty (PKP) in these patients.

Examination under anesthesia

The youngest patients undergo examination under anesthesia (EUA), because it is crucial to diagnose and manage children with a cloudy cornea accurately. The standard examination includes measurement of the refraction (if possible), IOP, corneal diameter, slit lamp evaluation, A/B-scan ultrasonography, and ultrasound biomicroscopy (UBM).

Pediatric transplant cases are especially challenging because of the severity of ocular pathologies, technical difficulties of operating on small eyes with elastic sclera, shallow anterior chambers, and anterior displacement of the iris and lens. The youngest patients are unable to cooperate and hard to examine. In addition, sudden rapid graft rejection can occur in these patients.

The indications for corneal transplantation in children include congenital disorders, which accounts for 65% such as Peters anomaly, sclerocornea, congenital hereditary, endothelial dystrophy, and congenital glaucoma; followed by acquired non-traumatic diseases in 20% of patients, such as keratoconus, herpes simplex virus (HSV), corneal ulcers, rosacea, and regrafts, and finally, trauma in 10%. This is in contrast to adults in whom endothelial disease accounts for 45% of cases, keratoconus 35%, failed grafts 15%, and finally, scars/opacities, according to Dr. Zaidman.

Parental involvement

Importantly, when evaluating and treating pediatric patients, surgeons have to be concerned with more than just the surgery itself.

This means evaluating the patients’ social situations and educating the parents about their participation in what he referred to as the “marathon” of office visits, EUAs, and drop instillation postoperatively.

“Surgeons must discuss with parents the realistic success rates in pediatric transplantation cases, and that a clear graft does not equal good vision,” he said

Early surgery

The timetable itself for infants with a congenital disorder can be daunting. The office visits begin before 3 weeks of age, and EUAs are performed from 4 to 6 weeks of age. Surgery in the first eye is performed between 8 to 12 weeks of age and in the second eye from 4 to 6 weeks after the first surgery. General anesthesia is administered (mannitol, hyperventilation).

Donor tissue is used from donors 4 to 19 years old; the donor tissue is oversized by 0.5 mm. A scleral support ring is put in place and the anterior chamber is entered carefully and a viscoelastic injected. Synechialysis then is performed.

‘Sandwich technique’ and suture removal

A special technique is used to excise the host cornea in children. This technique is designed to minimize the severe amount of positive pressure that pediatric corneal surgeons encounter during the surgery. It is called the “sandwich technique,” in which the donor cornea is placed onto the host cornea and sutured into position into the recipient’s sclera.

The recipient’s cornea then is slid out from under the donor cornea, avoiding vitreous/ lens prolapse. Interrupted sutures then are used to adhere the graft in place, Dr. Zaidman explained.

During the first 2 months postoperatively, the patient is examined two to three times weekly. EUAs are performed frequently during the early postoperative period, and the sutures are removed early during that period.

Over the long term, topical steroids are tapered slowly over the course of 1 year. Sedation is administered as needed.

‘No’ to vaccinations, ‘yes’ to oral medication

“The children receive no vaccinations during the first year postoperatively,” Dr. Zaidman said.

He also pointed out the importance of both co-management with a pediatric ophthalmologist and optical correction as soon as possible after the sutures are removed.

The long-term visual outcomes of PKP in children with Peters anomaly type I are often quite good.

Dr. Zaidman reported that at 3 years postoperatively, 90% of the eyes with Peters type I have clear grafts (2 regrafts), 29% have 20/50 or better, 25% of eyes have 20/60 to 20/100, and 54% of eyes have 20/100 or better vision. In his hands, no eyes were lost, and none had no light perception vision.

Most eyes with visual acuity of 20/200 or worse had glaucoma. Similar results also were reflected in the Australian Corneal Graft Registry, 1985-2009.

A total of 765 patients younger than 20 years was identified. In children younger than 5 years, 65% had Peters anomaly or a congenital defect and of these more than half (56%) had clear grafts.

Sixty-two percent of the children ranging in age from 5 to 12 years had keratoconus or an opacity or scar due to trauma or HSV; in 80% the grafts were clear. In children who were 13 to 19 years of age, 86% had keratoconus, and 90% had a clear graft. Endothelial rejection was the most common cause of graft failure, and glaucoma was the most common cause of poor vision.

Disclosures:

Gerald W. Zaidman, FAAO, FACS
E: pedkera@aol.com
Dr. Zaidman did not indicate any proprietary interest in the subject matter.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.